NCT04585945View on ClinicalTrials.gov

COVID-19 on Placental Gene Expression and Pathology

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

April 21, 2021

Study Completion Date

February 28, 2022

Conditions
COVID-19SARS-CoV-2 Infection
Interventions
DIAGNOSTIC_TEST

Positive for SARS-CoV-2 infection

Patients that have a positive test for SARS-CoV-2 infection during pregnancy, including at the time of delivery.

Trial Locations (1)

29605

Prisma Health Upstate, Greenville

All Listed Sponsors
lead

Prisma Health-Upstate

OTHER

NCT04585945 - COVID-19 on Placental Gene Expression and Pathology | Biotech Hunter | Biotech Hunter